Organon & Co. Reports Board Changes and Officer Compensation Updates
Ticker: OGN · Form: 8-K · Filed: Jan 21, 2025 · CIK: 1821825
| Field | Detail |
|---|---|
| Company | Organon & CO. (OGN) |
| Form Type | 8-K |
| Filed Date | Jan 21, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, executive-compensation, board-changes
Related Tickers: OGN
TL;DR
Organon's board is changing, and exec pay is getting updated.
AI Summary
Organon & Co. announced on January 15, 2025, changes in its board of directors and executive compensation arrangements. Specifically, the company reported the departure of a director and the election of a new director, along with updates to the compensatory arrangements for certain officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing reports routine corporate governance changes and compensation adjustments, which typically carry low inherent risk.
Key Players & Entities
- Organon & Co. (company) — Registrant
- January 15, 2025 (date) — Date of earliest event reported
- 001-40235 (other) — Commission File Number
- 46-4838035 (other) — I.R.S. Employer Identification No.
- 30 Hudson Street, Floor 33, Jersey City, NJ 07302 (location) — Address and principal executive offices
FAQ
What specific changes were made to the board of directors?
The filing indicates the departure of a director and the election of a new director, though their names are not specified in this excerpt.
When did the reported events occur?
The earliest event reported occurred on January 15, 2025.
What is Organon & Co.'s Commission File Number?
Organon & Co.'s Commission File Number is 001-40235.
Where are Organon & Co.'s principal executive offices located?
Organon & Co.'s principal executive offices are located at 30 Hudson Street, Floor 33, Jersey City, NJ 07302.
What type of information is being reported in this 8-K filing?
This 8-K filing reports on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
Filing Stats: 430 words · 2 min read · ~1 pages · Grade level 10.9 · Accepted 2025-01-21 07:01:34
Key Financial Figures
- $0.01 — h registered Common Stock, par value $0.01 per share OGN NYSE Indicate by ch
Filing Documents
- tm253756d1_8k.htm (8-K) — 23KB
- 0001104659-25-004711.txt ( ) — 192KB
- ogn-20250115.xsd (EX-101.SCH) — 3KB
- ogn-20250115_lab.xml (EX-101.LAB) — 33KB
- ogn-20250115_pre.xml (EX-101.PRE) — 22KB
- tm253756d1_8k_htm.xml (XML) — 4KB
02 Departure of Directors or Certain Officers; Election of Directors;
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 15, 2025, Organon & Co. (the " Company ") announced that effective January 15, 2025, Susanne Fiedler ceased performing her functions as Chief Commercial Officer. Ms. Fiedler will serve as a senior advisor to the Company until her departure, which is currently expected to be on or about April 30, 2025. Exhibit No. Description 104 The cover page of this Current Report on Form 8-K, formatted in Inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. Organon & Co. By: /s/ Kirke Weaver Name: Kirke Weaver Title: General Counsel & Corporate Secretary Dated: January 21, 2025